Add on the next level-the time point of the type I IFN response orchestrates the immune response.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
2020-04-28
Metadata
Show full item recordAbstract
[No abstract available]Citation
[published online ahead of print, 2020 Apr 28. Cell Mol Immunol. 2020;1‐3. doi:10.1038/s41423-020-0442-7Affiliation
HZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany.Publisher
Springer NatureJournal
Cellular & molecular immunologyPubMed ID
32346100PubMed Central ID
PMC7186764Additional Links
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186764/Type
ArticleLanguage
enEISSN
2042-0226ae974a485f413a2113503eed53cd6c53
10.1038/s41423-020-0442-7
Scopus Count
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International
Related articles
- Hepatitis B virus-specific T-cell responses during IFN administration in a small cohort of chronic hepatitis B patients under nucleos(t)ide analogue treatment.
- Authors: Sprinzl MF, Russo C, Kittner J, Allgayer S, Grambihler A, Bartsch B, Weinmann A, Galle PR, Schuchmann M, Protzer U, Bauer T
- Issue date: 2014
- Adding pegylated interferon to entecavir for hepatitis B e antigen-positive chronic hepatitis B: A multicenter randomized trial (ARES study).
- Authors: Brouwer WP, Xie Q, Sonneveld MJ, Zhang N, Zhang Q, Tabak F, Streinu-Cercel A, Wang JY, Idilman R, Reesink HW, Diculescu M, Simon K, Voiculescu M, Akdogan M, Mazur W, Reijnders JG, Verhey E, Hansen BE, Janssen HL, ARES Study Group
- Issue date: 2015 May
- Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B.
- Authors: Liem KS, van Campenhout MJH, Xie Q, Brouwer WP, Chi H, Qi X, Chen L, Tabak F, Hansen BE, Janssen HLA
- Issue date: 2019 Feb
- Long term response to therapy of chronic anti-HBe-positive hepatitis B is poor independent of type and schedule of interferon.
- Authors: Oliveri F, Santantonio T, Bellati G, Colombatto P, Mels GC, Carriero L, Dastoli G, Pastore G, Ideo G, Bonino F, Brunetto MR
- Issue date: 1999 May
- [Alterations of IFN-γ and IL-4 of peripheral blood T cells in patients with chronic HBV infection].
- Authors: Li M, Sun X, Zhou Z, Zhang X, Jin S, Gao Y, Gao Y
- Issue date: 2016 Feb